Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • MATIASGUIU, X; PRAT, J; YOUNG, RH; CAPEN, CC; DELELLIS; SCULLY, RE

    HUMaN PaRaTHYROID-HORMONE RELaTED PROTEIN (PTHRP) IN OVaRIaN SMaLL-CELL CaRCINOMaS - aN IMMUNOHISTOCHEMICaL STUDY

    LABORATORY INVESTIGATION 68 76-76. .

  • MATIASGUIU, X; KOMMINOTH, P; RICKLAN, D; WOLFE, H

    EXPRESSION OF THE RET PROTOONCOGENE IN HUMaN MEDULLaRY-THYROID CaRCINOMa - aN INSITU HYBRIDIZaTION STUDY

    LABORATORY INVESTIGATION 68 39-39. .

  • MATIASGUIU, X; RICKLAN, D; TRAN, T; WOLFE, H

    CHROMOSOME-1 aBNORMaLITIES IN MEDULLaRY-THYROID CaRCINOMa - a FLUORESCENCE INSITU HYBRIDIZaTION STUDY IN METaPHaSE aND INTERPHaSE TUMOR-CELLS

    LABORATORY INVESTIGATION 68 39-39. .

  • DENICTOLIS, M; MONTIRONI, R; TOMMASONI, S; CARINELLI, S; OJEDA, B; MATIASGUIU, X; PRAT, J

    SEROUS BORDERLINE TUMORS OF THE OVaRY - a CLINICOPaTHOLOGICaL, IMMUNOHISTOCHEMICaL, aND QUaNTITaTIVE STUDY OF 44 CaSES

    CANCER 70 152-160. .

    [doi:10.1002/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6]

  • PUJOL, RM; Casanova, JM; PEREZ, M; MATIASGUIU, X; PLANAGUMA, M; DEMORAGAS, JM

    FOCaL DERMaL HYPOPLaSIa (GOLTZ-SYNDROME) - REPORT OF 2 CaSES WITH MINOR CUTaNEOUS aND EXTRaCUTaNEOUS MaNIFESTaTIONS

    PEDIATRIC DERMATOLOGY 9 112-116. .

    [doi:10.1111/j.1525-1470.1992.tb01225.x]

  • CABALLERO, C; GOMEZ, S; MATIASGUIU, X; PRAT, J

    RHaBDOMYOSaRCOMaS DEVELOPING IN aSSOCIaTION WITH MEDIaSTINaL GERM-CELL TUMORS

    Virchows Archiv A-Pathological Anatomy And Histopathology 420 539-543. .

    [doi:10.1007/BF01600260]

  • IZQUIERDO, MA; OJEDA, B; PALLARES, C; ALONSO, MC; MATIASGUIU, X

    OVaRIaN-CaRCINOMa PRECEDED BY CEREBRaL METaSTaSIS - REVIEW OF THE LITERaTURE

    GYNECOLOGIC ONCOLOGY 45 206-210. .

    [doi:10.1016/0090-8258(92)90287-S]

  • PLANAGUMA, M; PUIG, L; ALOMAR, A; MATIASGUIU, X; DEMORAGAS, JM

    PYODERMa-GaNGRENOSUM IN aSSOCIaTION WITH ERYTHEMa-ELEVaTUM-DIUTINUM - REPORT OF 2 CaSES

    Cutis 49 201-206. .

  • AMPUDIA, X; PUIG, M; MATIAS, X; SOLDEVILA, J; PIERA, J; DELEIVA, A

    THYROID LYMPHOMa - a CLINICaL-PaTHOLOGICaL STUDY

    REVISTA CLINICA ESPANOLA 190 249-253. .

  • PRAT, J; MATIASGUIU, X; ALGABA, F

    DESMOPLaSTIC SMaLL ROUND-CELL TUMOR

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 16 306-307. .

    [doi:10.1097/00000478-199203000-00012]

  • MATIASGUIU, X; CAPELLA, G; ALEJO, M; PERUCHO, M; PRAT, J

    MUTaTED RaS ONCOGENES IN THYROID LESIONS

    LABORATORY INVESTIGATION 66 37-37. .

  • PRAT, J; MATIASGUIU, X; BARRETO, J

    SIMULTaNEOUS CaRCINOMa INVOLVING THE ENDOMETRIUM aND THE OVaRY - a CLINICOPaTHOLOGICaL, IMMUNOHISTOCHEMICaL, aND DNa FLOW CYTOMETRIC STUDY OF 18 CaSES

    CANCER 68 2455-2459. .

    [doi:10.1002/1097-0142(19911201)68:11<2455::AID-CNCR2820681122>3.0.CO;2-Q]

Projects

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU